Technology should make complex things feel simple, and human things feel amplified.
What drives me.
100s100s
of production deployments and brand launches shipped
55
therapeutic areas: immunology, rare disease, gene therapy, neuro and oncology. Brand after brand.
14+14+
years as a business owner, which taught me to run a department like one
Minutes, not days
I take slow, complicated work and turn it into tools a team runs in minutes.
Point of view
The constraint is never the technology.
In regulated marketing, building the tool is the easy part. Getting complex work through review and into people’s hands, in a form they’ll actually use, is the hard part. That’s the part I design.In regulated marketing, building the tool is the easy part. Getting complex work through review and into people’s hands, in a form they’ll actually use, is the hard part. That’s the part I design.
Simple is the hardest thing to build.
Anyone can add a tool. Turning a forty-step process into one a team runs in minutes takes real engineering. That is where the value is.
AI should amplify people, not replace judgment.
In pharma, a person signs off on everything. The best AI does the heavy lifting and hands that person a better decision, faster.
Governance is part of the product.
If it can’t get through medical, legal and regulatory review, it doesn’t ship. I design the approval path with the tool, not after it.
I’ve signed the front of a paycheck and the back of one. The biggest difference between running a company and running tech inside a big org isn’t the money, it’s how a decision gets made.
A tooling committee took four months to approve something I’d already been running productively for four months. The gap wasn’t bureaucracy, it was two different questions treated as one.